Cardinal Health is a medical distribution company located in Ohio, United States, which is part of the Healthcare sector, and is traded under the ticker CAH on the NYSE exchange.
Cardinal Health stock last closed at $190.77, up 0.49% from the previous day, and has increased 75.79% in one year. It has overperformed other stocks in the Medical Distribution industry by 0.25 percentage points. Cardinal Health stock is currently +72.44% from its 52-week low of $110.63, and -3.49% from its 52-week high of $197.67.
As of Oct 31, 2025, there are 237.6M CAH shares outstanding. The market capitalization of CAH is $45.33B. In the last 24 hours, 4.08M CAH shares were traded.
You will need a brokerage account in order to access the NYSE market and buy CAH shares.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, it's time to fill out some personal info so you are able to invest in CAH stock today.
Now that you have finished signing up on the stock trading app, your next step is to transfer the money for your investment:
Check out the video below if you need help depositing funds into your brokerage account.
After you have decided on the best place to buy Cardinal Health stock, it's very important to evaluate their stock prior to investing, so you can understand the risk and opportunity.
WallStreetZen was created to help part-time investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CAH's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CAH's fair value.
Using relative valuations metrics:
You can do additional valuation research on CAH's stock here.
Out of 7 Equities analysts who give ratings on CAH, the consensus analyst rating on CAH is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Michael Cherny, a top 14% analyst from Leerink Partners maintains CAH with a buy rating and lowers their CAH price target from $188.00 to $186.00, on Aug 12, 2025.
Leerink Partners's Michael Cherny lowered their price target on Cardinal Health (NYSE: CAH) by 1.1% from $188 to $186 on 2025/08/13. The analyst maintained their Buy rating on the stock.
Cardinal Health reported its Q4 and FY 2024 earnings.
Cutting their price target, Cherny acknowledged that "the stock's current weakness warranted," but argued that the Street is not giving " the totality of the quarter's results enough credit."
Expectations were high after 2025/006's "very robust" Investor Day in June, the analyst continued, "so seeing Pharma growth below consensus felt like a bit of a letdown.
But, Cherny posited, taking a step back and a deep breath, "it is important to keep in mind that management raised FY 2026 operational guidance just two months after the Investor Day, which was a sign of enterprise strength."
If Cardinal Health and peers continue to deliver double-digit AOI growth in their core segments, the analyst argued that the multiples do not reflect that level of stability.
Overall, Cherny said they are bullish on Cardinal Health and said the post-print dip was overdone.
Cardinal Health reported:
For Q4 2024:
For FY 2025:
CEO Jason Hollar commented: “Fiscal 2025 was a transformative year for Cardinal Health, and we closed the year with momentum, delivering strong fourth quarter results.
“The broad-based operational strength, with all five of our operating segments growing profit double-digits, reflects the disciplined execution of our strategy and our investments for growth.
"We enter Fiscal 2026 with confidence, evidenced by our increased financial outlook, as we continue to evolve towards reaching our full potential.”
Erin Wright, a top 6% analyst from Morgan Stanley maintains CAH with a strong buy rating and raises their CAH price target from $181.00 to $190.00, on Jul 16, 2025.
You can dive deeper into what analysts are saying on the Cardinal Health stock forecast page.
Last year, CAH earnings were $1.60B. In the last five year, CAH's earnings have gone up by 14.94% per year. This was slower than the Medical Distribution industry average of 20.81%.
Last year, CAH revenue was $234.31B. Over the last five year, CAH's revenue has gone up by 8.67% per year. This was slower than the Medical Distribution industry average of 10.11%.
You can analyze CAH's earnings and revenue performance here.
In the past year, insiders at CAH have sold more shares than they have bought.
Jason M. Hollar, Chief Executive Officer of CAH, was the latest CAH insider to sell. They sold $1,933,833.60 worth of CAH shares on Aug 20, 2025.
Learn more about who owns CAH stock here.
Cardinal Health pays a dividend of 0.8%, compared to the Medical Distribution industry's average dividend yield of 0.55%. If you owned $1,000 worth of CAH stock, you would have been paid $8.01 in the past year.
Cardinal Health dividend payments have consistently grown over the past decade and have remained stable.
Get more data about Cardinal Health dividend yield and history here.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary order types:
Hit the Open Trade button and your broker will execute your order.
If you want more help buying stocks on eToro, click the how to video below:
Now that you own some CAH shares, you'll want to keep up with your new investment.
Create a watchlist to keep track of your CAH stock.
To summarize, here are the 6 steps to buy stock in Cardinal Health:
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Cardinal Health, get started below.